BioSuperior Technology, Inc

Last week marked the close of our @NSFSBIR Bootcamp Program. In my presentation to this group, I summarized 32 expert interviews that we carried out. The insights from these interviews are tremendously helpful in refining our product development and commercialization plans.

Do you care about bronchopulmonary dysplasia? If yes, please feel free to share.

Russ Lehrman, Ph.D. @SRLehrman Replying to @lolitataub 🦄Co: BioSuperior Technology 🌱Stage: Seed 📍Country: US 📑Structure: DE C Corp 🤩Team: @SRLehrman 📝1-liner: Developing novel treatment for bronchopulmonary dysplasia (BPD) in pre-term infants. 🙌🏽Current funding: $500K+

Just returned from #Boston after attending the #RESI conference hosted by @LSciNation. I look forward to sharing my takeaways in an upcoming blog.

This is an important initiative. Great to see a coordinated research effort on this topic. #COVID19

A good day for biomedical research. nytimes.com/2022/09/12/us/po…

#LongCovid takes many forms. There's still much to learn about this disease and more therapeutic developments need to be developed. @BioSuperiorTech nbcnews.com/health/health-ne…

Thanks to @jonstewart for shining a floodlight on the catastrophic toll of burn pit exposure in the military. We're sure that you will keep up the advocacy, Jon - our company is working to develop treatments that repair lungs damaged by burn pit exposure. @BioSuperiorTech

Important perspective from Dr. Lance Prince (@DrLancePrince, Stanford Med) speaking @pwmc2022: bronchopulmonary dysplasia (BPD) is a risk factor for COPD later in life.

Increasing morbidity and mortality due to lung disease demands far more attention than these diseases currently receive.

The last point particularly grabs my attention. Our company is working to change this reality. #COVID19 @BioSuperiorTech

In a Webinar with @vidalung Dr. MeiLan Han said:“If trials could be done more efficiently and less expensively, we’d see more investment in respiratory disease.” This is an important insight that BioSuperior recognizes and will incorporate into our clinical trials.

Hearing Jerry Harrison make sense of the parallels between establishing a rock band and a #startup is fascinating. Great job! youtu.be/WQab2xzXiuA

Dr. Ehud Goldin and I will be attending #PMWC22, hosted by @PMWCintl this week. The event theme is "Transforming Every Patient Outcome", an audacious and laudable goal. We look forward to our interactions with scientists and investors.

As a lifelong Mets fan and as the founder of a company that is developing new treatments for pre-term babies with serious lung illness, I was thrilled to see this tweet! Way to go, Jessica and James! #BPD #NRDS #LGM

Just wrapped up the Digital #RESI June Conference hosted by @LSciNation. It was great speaking to potential investors and getting more perspective from meeting perspective. | #excited #KeepBreathing

Very important article. Key takeaway - nasal delivery of vaccine may be more protective than injection. Sheikh-Mohamed, S., et al. doi.org/10.1038/s41385-022-0… #COVID19

Pleased to announced we now have an official company twitter account @BioSuperiorTech | Follow us there for the latest updates and developments | #Biotech #KeepBreathing

Research Innovation Summit #ATS2022. Biotech entrepreneurs typically hear that VCs look for companies that are do great science with a great team. But the insights at RIS went much deeper. How to design the target product profile. Dynamics within the "team"..and more. Helpful!